Inclusion Criteria:  Provision of informed consent to study Age ≥ 18 years Receiving two doses of the BNT162b2 vaccine  Exclusion Criteria:  patients who did not complete 2-dose vaccination schedule patients who received any other vaccine than BNT162b2 patients considered by investigator to be unable to cooperate